Novartis' Christine Brennan joins Vitae
Published on: 26/07/10
US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer.
She has over 10 years industry experience and moves to Vitae from Novartis’ Institutes for BioMedical Research, where she served as executive director and head of strategy and operations for strategic alliances.
Vitae’s chief executive Jeffrey Hatfield commented: “We are very pleased to welcome Christine to Vitae at this stage of our growth. The life sciences industry is tracking on a path of tremendous change, centered around a rapidly increasing link - even co-dependency - between large pharma and biotech.
“Her successful partnering experiences in each, her proven track record of creating value through collaboration, and her strategic insights and leadership skills will all strongly contribute to Vitae’s continued maturation.”
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
